Evidence map›Paper›PMID 33976282›Full record

ArticleScientific reports2021

Distinguishing active from quiescent disease in ANCA-associated vasculitis using attenuated total reflection Fourier-transform infrared spectroscopy.

Adam D Morris, Camilo L M Morais, Kássio M G Lima, Daniel L D Freitas, Mark E Brady, Ajay P Dhaygude, Anthony W Rowbottom, Francis L Martin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Adam D MorrisDepartment of Renal Medicine, Royal Preston Hospital, Lancashire NHS Foundation Trust, Preston, UK. Adam.Morris@lthtr.nhs.uk.
Camilo L M MoraisSchool of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, UK.
Kássio M G LimaInstitute of Chemistry, Biological Chemistry and Chemometrics, Federal University of Rio Grande Do Norte, Natal, Brazil.
Daniel L D FreitasInstitute of Chemistry, Biological Chemistry and Chemometrics, Federal University of Rio Grande Do Norte, Natal, Brazil.
Mark E BradyDepartment of Renal Medicine, Royal Preston Hospital, Lancashire NHS Foundation Trust, Preston, UK.
Ajay P DhaygudeDepartment of Renal Medicine, Royal Preston Hospital, Lancashire NHS Foundation Trust, Preston, UK.
Anthony W RowbottomDepartment of Immunology, Royal Preston Hospital, Lancashire NHS Foundation Trust, Preston, UK.
Francis L MartinBiocel UK Ltd, Hull, UK. flm13@biocel.uk.
Royal Preston Hospital · GBUniversity of Central Lancashire · GBUniversidade Federal do Rio Grande · BRUniversidade Federal do Rio Grande do Norte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current lack of a reliable biomarker of disease activity in anti-neutrophil cytoplasmic autoantibody (ANCA) associated vasculitis poses a significant clinical unmet need when determining relapsing or persisting disease. In this study, we demonstrate for the first time that attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy offers a novel and functional candidate biomarker, distinguishing active from quiescent disease with a high degree of accuracy. Paired blood and urine samples were collected within a single UK centre from patients with active disease, disease remission, disease controls and healthy controls. Three key biofluids were evaluated; plasma, serum and urine, with subsequent chemometric analysis and blind predictive model validation. Spectrochemical interrogation proved plasma to be the most conducive biofluid, with excellent separation between the two categories on PC2 direction (AUC 0.901) and 100% sensitivity (F-score 92.3%) for disease remission and 85.7% specificity (F-score 92.3%) for active disease on blind predictive modelling. This was independent of organ system involvement and current ANCA status, with similar findings observed on comparative analysis following successful remission-induction therapy (AUC > 0.9, 100% sensitivity for disease remission, F-score 75%). This promising technique is clinically translatable and warrants future larger study with longitudinal data, potentially aiding earlier intervention and individualisation of treatment.

Indexed as

Spectroscopy, Fourier Transform InfraredAgedAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisBiomarkersFemaleHumansMaleMiddle AgedProof of Concept StudyBiomarkers

Identifiers

PMID33976282
PMCPMC8113456
OpenAlexW3160091336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.